D
Revolution Medicines, Inc. RVMD
$39.12 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -600.09M -567.06M -519.21M -484.27M -436.37M
Total Depreciation and Amortization 10.72M 10.20M 9.46M 8.44M 8.21M
Total Amortization of Deferred Charges 1.10M 1.10M 1.10M 1.10M 1.10M
Total Other Non-Cash Items 30.43M 36.52M 32.38M 33.50M 39.73M
Change in Net Operating Assets 406.00K -20.46M -33.53M -7.51M 36.75M
Cash from Operations -557.44M -539.71M -509.79M -448.74M -350.57M
Capital Expenditure -10.31M -11.40M -10.42M -9.14M -7.73M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -544.09M -530.49M -432.65M -585.42M -334.87M
Cash from Investing -554.39M -541.89M -443.07M -594.56M -342.60M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 863.71M 88.15M 11.87M 69.00M 392.39M
Repurchase of Common Stock -- -4.03M -4.03M -4.03M -4.03M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 95.71M 840.83M 840.83M 840.83M 840.83M
Cash from Financing 959.41M 924.96M 848.68M 905.81M 1.23B
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -152.42M -156.64M -104.18M -137.50M 536.03M
Weiss Ratings